The importance of real-world evidence in transforming healthcare decision-making
Over the last 20 years, US healthcare has shifted to a value-based system, with payers and healthcare providers being challenged…
sponsored
-
-
Free webinar: Ensuring compliance-first logistics for reliable clinical trials
According to GlobalData, industry-sponsored trials have increased from 7,721 in 2016 to 13, 685 in 2025. This growth over the…
-
The value of real-world data for healthcare marketing
Marketing has evolved significantly since the time when a marketing plan would ignore market segment differences and appeal to the…
-
Eco-design: Shaping the future of pharma packaging
Pharmaceutical companies are striving to balance complex and evolving regulatory demands, operational efficiency challenges, and environmental responsibility in an age…
-
Low concentrations are no obstacle to detection in gas chromatography analysis
Gas chromatography (GC) remains an indispensable analytical tool in the pharmaceutical industry, supporting tasks ranging from residual solvent analysis and…
-
Innovation meets convenience: Redefining lyophilized drug delivery for patients
Over the past few decades, the pharmaceutical industry has seen a steady shift toward parenteral self-administration and home-based care. As…
-
ViiV Healthcare launches ‘Risk to Reasons’ initiative in the UK to empower women to take control of their HIV prevention choices
While surveillance data from 2024 shows an encouraging reduction in HIV transmissions1, more needs to be done to meet the…
-
How next-gen medical textiles combine comfort, safety, and sustainability
Every year, millions of disposable gowns end up in medical waste incinerators. But a new generation of sustainable textiles is…
-
ESMO 2025: Data, decisions, and the future of oncology
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
-
The future of high-potency APIs: Strategies for manufacturing challenges
The growing friction between the US and China has serious consequences for the supplies of high-potency active pharmaceutical ingredients (HPAPIs),…
